ArticleResearch square2024

Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer Immunotherapy.

John Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.